Erika Levine, MD
Dermatology · Voorhees, NJNPI 1487742508
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $455 and has fallen 64.6% since, to $161 in 2025. That places this record below the midpoint for dermatology clinicians in NJ, where the typical reported total is $1,986.
Across 104 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$176
- Novartis$168
- AbbVie$151
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$144
- E.r. Squibb & Sons, L.L.C.$128
- Galderma Laboratories, L.p.$116
- plus $824 from 18 others
What the payments were for
- Food & beverage$1,60994%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $176 |
| Novartis | 12 | $168 |
| AbbVie | 10 | $151 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $144 |
| E.r. Squibb & Sons, L.L.C. | 8 | $128 |
| Galderma Laboratories, L.p. | 8 | $116 |
| LEO Pharma Inc. | 7 | $104 |
| Sun Pharmaceutical Industries Inc. | 6 | $95 |
| Regeneron Healthcare Solutions, Inc. | 1 | $92 |
| Incyte Corporation | 5 | $82 |
| Lilly USA, LLC | 5 | $75 |
| UCB, Inc. | 5 | $69 |
| Arcutis Biotherapeutics, Inc. | 4 | $62 |
| Almirall LLC | 3 | $45 |
| Amgen | 2 | $34 |
| Biofrontera Inc. | 2 | $32 |
| Dermavant Sciences, Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Sanofi | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $15 |
| Botanix SB Inc | 1 | $14 |
| Journey Medical Corporation | 1 | $13 |
| Pfizer | 1 | $12 |
| Organon | 1 | $2 |
How this compares
$1,709 in reported general payments places this provider in the 45th percentile of 394 dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 114 | $5,627 |
| Clobetasol Propionate | 49 | $2,641 |
| Ketoconazole | 112 | $2,615 |
| Tacrolimus | 12 | $1,847 |
| Betamethasone Dipropionate | 55 | $1,709 |
| Triamcinolone Acetonide | 121 | $1,480 |
| Desonide | 41 | $1,366 |
| Tretinoin | 18 | $858 |
| Fluorouracil | 14 | $828 |
| Metronidazole | 27 | $738 |
| ValacyclovirValacyclovir Hcl | 38 | $673 |
| Alclometasone Dipropionate | 14 | $561 |
| Clindamycin Phosphate | 32 | $548 |
| Mupirocin | 44 | $171 |
| Nystatin | 15 | $154 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Voorhees
- Ronald BernardinVoorhees$688K
- David FinkelsteinVoorhees$21K
- Omar NoorSomerset$4.5M
- Linda Cappiello-LindsleyHoboken$2.3M
- Brian KeeganEast Windsor$1.7M
- Jerry BagelEast Windsor$1.6M
- Mital Patel CohenFlorham Park$799K
- Brian MachlerFlorham Park$346K
- Jeanine DownieMontclair$327K
- Aanand GeriaRutherford$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.